Hyloris Pharmaceuticals SA (HYL)
EU
年末 2023年12月31日 | 2017 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
総売上 | 0 | 213k | 91k | 91k | 175k | 3.1M | 2.39M | 4.21M |
営業利益 | 0 | -3.87M | -5.47M | -5.27M | -7.05M | -10.54M | -11.64M | -15.99M |
税引前収入 | 0 | -3.78M | -6.06M | -5.78M | -7.14M | -11.28M | -11.9M | -15.38M |
純利益 | 0 | -3.72M | -5.79M | -5.37M | -7.15M | -11.58M | -11.91M | -15.38M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | -1.267 | -1.713 | -1.207 | -0.277 | -0.448 | -0.425 | -0.549 |
EBIT | 0 | -3.87M | -5.47M | -5.27M | -7.02M | -10.54M | -11.64M | -15.99M |
EBITDA | 0 | -3.8M | -5.38M | -1.97M | -6.46M | -10.41M | -11.64M | -15.99M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約